Under construction – not a live service

Skip to content

Frontlight Research

Institution

Hôpital Fernand-Widal

Paris, FranceWebsite

Also known as: CHU Fernand-Widal

2running trials
1closed trial

Running trials

Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
NCT07011745· Phase 3· Bristol-Myers Squibb· Source
Recruiting
Melatonin and Response to Lithium
NCT05878730· Assistance Publique - Hôpitaux de Paris· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Completed
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults with Upper Limb Spasticity
2023-509196-16-00· Phase 4· Ipsen Pharma· Source

Registry name variants (1)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Hopital Fernand Widal
Paris, 75010
3 trials
- NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- NCT05878730Melatonin and Response to Lithium
  Contact: Vincent Hennion, MD
- 2023-509196-16-00A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults with Upper Limb Spasticity

Institution data: ROR 01zkyzz15 (CC0-1.0)Updated 7 Nov 2026

Report an error

Under construction, not live – Hôpital Fernand-Widal: trials and research groups – Frontlight Research